PDCD1 and neoplasm: Within the tumor microenvironment, Tumor cells robustly upregulate PD-L1 expression via mechanisms such as genetic mutations, hypoxia, and inflammatory stimuli (e.g., IFN-γ) the PD-1/PD-L1 signaling pathway is exploited to facilitate immune evasion (16, 17).